Download PDF
Thromb Haemost 1997; 77(01): 214-216
DOI: 10.1055/s-0038-1655933
Letter to the Editor
Schattauer GmbH Stuttgart

Prevalence of Factor V Leiden in Young Adults with Retinal Vein Occlusion

Tuuli Linna
1   The Department of Ophthalmology, University of Helsinki, Finland
,
Antti Ylikorkala
2   The Department of Medicine, University of Helsinki, Finland
,
Kimmo E Kontula
2   The Department of Medicine, University of Helsinki, Finland
,
Päivi Puska
1   The Department of Ophthalmology, University of Helsinki, Finland
,
Timo Tervo
1   The Department of Ophthalmology, University of Helsinki, Finland
› Author Affiliations
Further Information

Publication History

Received 03 June 1996

Accepted after revision 01 October 1996

Publication Date:
11 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Sanborn GE, Magargal LE, Jaeger EA. Venous occlusive disease of the retina. In: Duane's Clinical Ophthalmology, Diseases of the Retina, Glaucoma (Vol 3). Tasman W. ed. 1994 JB Lippincott Company; Philadelphia: 1994. pp 1-29
    Google Scholar
  • 2 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedGoogle Scholar
  • 3 Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993
    PubMedGoogle Scholar
  • 4 Koster T, Rosendaal FR, de RondeH, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
    CrossrefPubMedGoogle Scholar
  • 5 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
    CrossrefPubMedGoogle Scholar
  • 6 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de RondeH, van der VeldenPA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 7 Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524
    CrossrefPubMedGoogle Scholar
  • 8 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
    CrossrefPubMedGoogle Scholar
  • 9 Hakala L, Vahtera E, Krusius T, Rasi V. APC-resistenssi ja hyytymistekijä V:n mutaatio suomalaisilla tromboosipotilailla (in Finnish). Duodecim 1995; 22: 2143-2151
    PubMedGoogle Scholar
  • 10 Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Brit J Ophthalmol 1996; 80: 200-202
    CrossrefPubMedGoogle Scholar
  • 11 Williamson TH, Rumley A, Lowe GDO. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Brit J Ophthalmol 1996; 80: 203-208
    CrossrefPubMedGoogle Scholar
  • 12 de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-886
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Engel H, Zwang L, van VlietHHDM, Michiels JJ, Stibbe J, Lindemans J. Phenotyping and genotyping of coagulation factor V Leiden. Thromb Haemost 1996; 75: 267-269
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Alhadyan AA. Retinal vein occlusion in Saudi-Arabia: possible role of dehydration. Ann Ophthalmol 1993; 25: 394-398
    PubMedGoogle Scholar